On Tuesday, Yoga Guru Baba Ramdev and Acharya Balakrishna will launch first ayurvedic medicine ‘Divya Coronil Tablet‘ for the treatment of COVID-19 patients. Patanjali Yogpeeth has stated that this research done on the corona tablet is the result of joint efforts of Patanjali Research Institute Haridwar and National Institute of Medical Science Jaipur. The tablet is being manufactured at Divya Pharmacy and Patanjali Ayurved Limited Haridwar. During this time, teams of scientists, researchers and doctors will also be present.
Earlier this month, Acharya Balakrishna, General Secretary of Patanjali Yogpeeth and Vice-Chancellor of Patanjali Ayurvedic University claimed that after five months of research at Patanjali Research Institute and after several rounds of successful trials on mice. The clinical case study required for this has been completed, while the clinical control trial is in its final stages. As soon as its data is available, the final analysis will be done and put into the drug market.
Proud launch of first and foremost evidence-based ayurvedic medicine for #corona contagion, #SWASARI_VATI, #CORONIL, is scheduled for tomorrow at 12 noon from #Patanjali Yogpeeth Haridwar🙏🏻 pic.twitter.com/K7uU38Kuzl
— Acharya Balkrishna (@Ach_Balkrishna) June 22, 2020
Components of ‘Divya Coronil Tablet’:
According to Acharya Balakrishna, the main components of the medicine are Ashwagandha, Giloy, Tulsi, Shwassari juice and atomic oil. Their mixture and proportion have been decided according to research. He had also claimed that this medicine is authentic from all major institutions, journals, etc., nationally and internationally, depending on its use, treatment and effectiveness. This research has also been published in the International Journal of Biomedicine Pharmacotherapy of America.
This is ‘Divya Coronil Tablet’ works:
Acharya Balakrishna said that Ashwagandha does not allow COVID-19’s RBD to meet the ACE of the human body. This prevents the coronavirus from entering the healthy cells of the infected human body. Giloy also acts like Ashwagandha. This prevents infection from occurring. Tulsi’s compound not only inhibits the rate of increase in coefficients of COVID-19 by attacking RNA-polymerase but also eliminates its frequent intake. Respiratory juice prevents the formation of thick mucus and reduces inflammation of the lungs by eliminating mucus. Similarly, atomic oil can be used as a nasal drop.
300 researchers took part in research:
Acharya Balakrishna said that the discovery of COVID-19 drug ‘Divya Coronil Tablet’ was started in December 2019 after reports of the increasing virus in China. Its case study was done first and from January 2020, research was started for its drug discovery regarding the behavior and effects of the virus. About 300 research scholars of Patanjali Yogpeeth Research Center participated in this work. It is reported that the drug has been approved by the ‘Clinical Trial Registry of India’. It will be available in the market from Tuesday.